John Aballi Exagen Inc. (XGN) insider trading activity

John Aballi is President and CEO of EXAGEN INC.. Currently has a direct ownership of 746,214 shares of XGN, which is worth approximately $2.88 Million. The most recent transaction as insider was on Feb 28, 2025, when has been sold 8,621 shares (Common Stock) at a price of $2.46 per share, resulting in proceeds of $21,207. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 746K

8.18% 3M change

24.21% 12M change

Total Value Held $2.88 Million

JOHN ABALLI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	BUY Grant, award, or other acquisition	$21,207 $2.46 p/Share	8,621 Added 1.14%	746,214 Common Stock
Feb 21 2025	BUY Grant, award, or other acquisition	-	112,500 Added 13.23%	737,593 Common Stock
Nov 14 2024	BUY Open market or private purchase	$68,297 $2.81 p/Share	24,305 Added 3.4%	689,799 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	$18,725 $1.91 p/Share	9,804 Added 1.61%	600,788 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	175,000 Added 22.85%	590,984 Common Stock
Oct 17 2023	SELL Open market or private sale	$59,183 $1.75 p/Share	33,819 Reduced 7.52%	415,984 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	$20,978 $2.14 p/Share	9,803 Added 2.13%	449,803 Common Stock
Dec 08 2022	BUY Open market or private purchase	$241,200 $2.68 p/Share	90,000 Added 16.98%	440,000 Common Stock
Oct 16 2022	BUY Grant, award, or other acquisition	-	350,000 Added 50.0%	350,000 Restricted Stock Units

John Aballi

President and CEO

Vista, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XGN shares.

Notify only if

Value

Insider Trading

Get notified when an Exagen Inc. insider buys or sells XGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXAGEN INC.

Track Activities on XGN

Account